Hohlfeld R - Search Results

1

Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial.

Kappos L, O'Connor P, Radue EW, Polman C, Hohlfeld R, Selmaj K, Ritter S, Schlosshauer R, von Rosenstiel P, Zhang-Auberson L, Francis G. Kappos L, et al. Among authors: hohlfeld r. Neurology. 2015 Apr 14;84(15):1582-91. doi: 10.1212/WNL.0000000000001462. Epub 2015 Mar 20. Neurology. 2015. PMID: 25795646 Free PMC article. Clinical Trial.

2

Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis.

Hohlfeld R, Michels M, Heininger K, Besinger U, Toyka KV. Hohlfeld R, et al. Neurology. 1988 Feb;38(2):258-61. doi: 10.1212/wnl.38.2.258. Neurology. 1988. PMID: 3340289

3

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives.

Hohlfeld R. Hohlfeld R. Brain. 1997 May;120 ( Pt 5):865-916. doi: 10.1093/brain/120.5.865. Brain. 1997. PMID: 9183256 Review.

4

[Interferon beta-1b for treatment of secondary chronic progressive multiple sclerosis].

Zimmermann C, Walther EU, Goebels N, Lienert C, Kappos L, Hartung HP, Hohlfeld R. Zimmermann C, et al. Among authors: hohlfeld r. Nervenarzt. 1999 Aug;70(8):759-63. doi: 10.1007/s001150050508. Nervenarzt. 1999. PMID: 10483579 Clinical Trial. German.

5

Multiple sclerosis: side effects of interferon beta therapy and their management.

Walther EU, Hohlfeld R. Walther EU, et al. Among authors: hohlfeld r. Neurology. 1999 Nov 10;53(8):1622-7. doi: 10.1212/wnl.53.8.1622. Neurology. 1999. PMID: 10563602 Review.

6

[Multiple sclerosis. Current review of failed and discontinued clinical trials of drug treatment].

Wiendl H, Neuhaus O, Kappos L, Hohlfeld R. Wiendl H, et al. Among authors: hohlfeld r. Nervenarzt. 2000 Aug;71(8):597-610. doi: 10.1007/s001150050636. Nervenarzt. 2000. PMID: 10996910 Free PMC article. Review. German.

7

The recognition, diagnosis and management of cerebral vasculitis: a European survey.

Scolding NJ, Wilson H, Hohlfeld R, Polman C, Leite I, Gilhus N; EFNS Cerebral Vasculitis Task Force. Scolding NJ, et al. Among authors: hohlfeld r. Eur J Neurol. 2002 Jul;9(4):343-7. doi: 10.1046/j.1468-1331.2002.00422.x. Eur J Neurol. 2002. PMID: 12099915

8

A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS.

Clanet M, Radue EW, Kappos L, Hartung HP, Hohlfeld R, Sandberg-Wollheim M, Kooijmans-Coutinho MF, Tsao EC, Sandrock AW; European IFNbeta-1a (Avonex) Dose-Comparison Study Investigators. Clanet M, et al. Among authors: hohlfeld r. Neurology. 2002 Nov 26;59(10):1507-17. doi: 10.1212/01.wnl.0000032256.35561.d6. Neurology. 2002. PMID: 12451189 Clinical Trial.

9

Interferon beta-1a in relapsing multiple sclerosis: four-year extension of the European IFNbeta-1a Dose-Comparison Study.

Clanet M, Kappos L, Hartung HP, Hohlfeld R; European IFNbeta-1a Dose-Comparison Study Investigators. Clanet M, et al. Among authors: hohlfeld r. Mult Scler. 2004 Apr;10(2):139-44. doi: 10.1191/1352458504ms990oa. Mult Scler. 2004. PMID: 15124757 Clinical Trial.

10

Neuroprotection in multiple sclerosis report from the MS Forum 16th Modern Management Workshop, March 2004, Cernobbio, Italy.

Hohlfeld R, Kappos L. Hohlfeld R, et al. Int MS J. 2004 Sep;11(2):61-3. Int MS J. 2004. PMID: 15279736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters